尿肾损伤分子-1和可溶性髓样细胞触发受体-1对脓毒症相关急性肾损伤的早期诊断价值

黄楔山, 孙自国, 李艳, 等. 尿肾损伤分子-1和可溶性髓样细胞触发受体-1对脓毒症相关急性肾损伤的早期诊断价值[J]. 临床急诊杂志, 2020, 21(6): 488-492,498. doi: 10.13201/j.issn.1009-5918.2020.06.014
引用本文: 黄楔山, 孙自国, 李艳, 等. 尿肾损伤分子-1和可溶性髓样细胞触发受体-1对脓毒症相关急性肾损伤的早期诊断价值[J]. 临床急诊杂志, 2020, 21(6): 488-492,498. doi: 10.13201/j.issn.1009-5918.2020.06.014
HUANG Xieshan, SUN Ziguo, LI Yan, et al. Early diagnostic value of urinary KIM-1 and sTREM-1 in septic AKI[J]. J Clin Emerg, 2020, 21(6): 488-492,498. doi: 10.13201/j.issn.1009-5918.2020.06.014
Citation: HUANG Xieshan, SUN Ziguo, LI Yan, et al. Early diagnostic value of urinary KIM-1 and sTREM-1 in septic AKI[J]. J Clin Emerg, 2020, 21(6): 488-492,498. doi: 10.13201/j.issn.1009-5918.2020.06.014

尿肾损伤分子-1和可溶性髓样细胞触发受体-1对脓毒症相关急性肾损伤的早期诊断价值

详细信息
    通讯作者: 孙自国,E-mail:sunziguozzyx@163.com
  • 中图分类号: R631.2

Early diagnostic value of urinary KIM-1 and sTREM-1 in septic AKI

More Information
  • 目的:探讨尿肾损伤分子-1(KIM-1)、可溶性髓样细胞触发受体1(sTREM-1)对脓毒症相关急性肾损伤(SA-AKI)的早期诊断价值。方法:选取2017-08—2019-05期间本院收治的脓毒症患者121例,依据其是否发生SA-AKI,分为AKI组(39例)和非AKI组(82例)。单因素和多因素Logistic回归分析临床资料确定SA-AKI发生的高危因素。采用酶联免疫吸附法测定患者0、12、24 h尿KIM-1和sTREM-1水平。应用受试者工作特征(ROC)曲线分析不同时间点尿KIM-1和sTREM-1水平对SA-AKI的早期诊断价值。结果:SA-AKI的发病率为33.23%(39/121)。与非AKI组相比,AKI组患者血SCr、尿KIM-1、尿sTREM-1和APACHEⅡ评分明显升高,差异具有统计学意义(P<0.05)。多因素Logistic回归分析显示,SCr、尿KIM-1和尿sTREM-1是SA-AKI患者的独立危险因素。在12 h和24 h,AKI组尿KIM-1和sTREM-1水平均明显高于非AKI组,差异有统计学意义(P<0.05)。与24 h尿KIM-1联合sTREM-1对AKI预测效能相比,12 h尿KIM-1联合sTREM-1具有更高的预测效能(Z=4.632,P<0.05),其ROC曲线下面积为0.948(95%CI:0.907~0.989),其诊断灵敏度为93.58%,特异度为87.69%。结论:SA-AKI患者在12 h时尿KIM-1和sTREM-1表达水平明显升高,尿KIM-1和sTREM-1可以作为早期诊断SA-AKI的有效生物标志物,联合检测具有更高的预测效能。
  • 加载中
  • [1]

    Singer M,Deutschman CS,Seymour CW,et al.The third international consensus definitions for sepsis and septic shock(sepsis-3)[J].JAMA,2016,315(8):801-810.

    [2]

    Westhoff JH,Seibert FS,Waldherr S,et al.Urinary calprotectin,kidney injury molecule-1,and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury[J].Eur J Pediatr,2017,176(6):745-755.

    [3]

    Song J,Yu J,Prayogo GW,et al.Understanding kidney injury molecule 1:a novel immune factor in kidney pathophysiology[J].Am J Transl Res,2019,11(3):1219-1229.

    [4]

    Dai X,Zeng Z,Fu C,et al.Diagnostic value of neutrophil gelatinase-associated lipocalin,cystatin C,and soluble triggering receptor expressed on myeloid cells-1 in critically ill patients with sepsis-associated acute kidney injury[J].Crit Care,2015,19:223.

    [5]

    Khwaja A.KDIGO clinical practice guidelines for acute kidney injury[J].Nephron Clin Pract,2012,120(4):c179-c184.

    [6]

    Bland SK,Schmiedt CW,Clark ME,et al.Expression of kidney injury molecule-1 in healthy and diseased feline kidney tissue[J].Vet Pathol,2017,54(3):490-510.

    [7]

    Lei L,Li LP,Zeng Z,et al.Value of urinary KIM-1 and NGAL combined with serum Cys C for predicting acute kidney injury secondary to decompensated cirrhosis[J].Scientific Reports,2018,8(1):7962.

    [8]

    钟开义,黎宝仁,张祖文,等.尿KIM-1、NGAL及L-FABP在老年重症患者急性肾损伤早期诊断中的价值[J].临床急诊杂志,2018,19(12):850-854.

    [9]

    Sharif O,Knapp S.From expression to signaling:roles of TREM-1 and TREM-2 in innate immunity and bacterial infection[J].Immunobiology.2008;213(9-10):701-13.

    [10]

    Su L,Xie L,Liu D.Urine sTREM-1 may be a valuable biomarker in diagnosis and prognosis of sepsis-associated acute kidney injury[J].Crit Care.2015,19:281.

    [11]

    严洁,臧芝栋.sTREM-1和NGAL对脓毒血症并发急性肾损伤早期诊断的预测价值[J].中华肾脏病杂志,2013,29(6):423-428.

    [12]

    张盼,赵会海,郝玉青,等.尿NGAL和KIM-1及IL-18在脓毒症并发急性肾损伤中的早期诊断价值[J].临床急诊杂志,2019,20(7):541-546.

    [13]

    温莉玲,陈家佳,梁红丽.尿NGAL、KIM-1联合APACHE Ⅱ评分对脓毒症急性肾损伤诊断及预后的价值[J].临床急诊杂志,2019,20(2):110-114.

  • 加载中
计量
  • 文章访问数:  127
  • PDF下载数:  152
  • 施引文献:  0
出版历程
收稿日期:  2020-01-26

目录